ROLE OF ANGIOTENSIN-II IN BLOOD-PRESSURE REGULATION AND IN THE PATHOPHYSIOLOGY OF CARDIOVASCULAR DISORDERS

被引:0
|
作者
FYHRQUIST, F
METSARINNE, K
TIKKANEN, I
机构
关键词
ANGIOTENSIN II; BLOOD PRESSURE REGULATION; PATHOPHYSIOLOGY;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Angiotensin II (Ang II) raises blood pressure (BP) by a number of actions, the most important ones being vasoconstriction, sympathetic nervous stimulation, increased aldosterone biosynthesis and renal actions. Other Ang II actions include induction of growth, cell migration, and mitosis of vascular smooth muscle cells, increased synthesis of collagen type I and III in fibroblasts, leading to thickening of the vascular wall and myocardium, and fibrosis. These actions are mediated by type 1 Ang II receptors (AT(1)), and may be blocked by losartan, a specific blocker of AT(1) receptors. In particular, studies employing losartan have shown that Ang II is an important contributor to BP regulation and plays a significant role in hypertension and in the pathophysiology of vascular damage during the course of hypertension. Ang II is also involved in the process of atherosclerosis and in remodelling and repair processes of the myocardium following myocardial infarction. Finally, increased Ang II is an important part of neurohumoral activation in heart failure. Exciting new discoveries concerned with polymorphisms of genes coding for angiotensin converting enzyme (ACE) and angiotensinogen suggest that Ang II may be genetically associated with increased risk for myocardial infarction, hypertension and left ventricular hypertrophy.
引用
收藏
页码:S19 / S24
页数:6
相关论文
共 50 条
  • [21] CEREBROVENTRICULAR INJECTION OF ANGIOTENSIN-II ANTAGONIST - EFFECTS ON BLOOD-PRESSURE RESPONSES TO CENTRAL AND SYSTEMIC ANGIOTENSIN-II
    GORBEAOPPLIGER, VJ
    FINK, GD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 273 (02): : 611 - 616
  • [22] THE SYNERGISTIC EFFECT OF ANGIOTENSIN-II AND UREA ON SYSTEMIC BLOOD-PRESSURE
    CORLEY, KC
    CHAN, JCM
    MAUCK, HP
    GIPSON, J
    OWUSU, K
    INTERNATIONAL JOURNAL OF PEDIATRIC NEPHROLOGY, 1986, 7 (04): : 227 - 232
  • [23] BLOOD-PRESSURE EFFECTS OF THE ANGIOTENSIN-II RECEPTOR BLOCKER, LOSARTAN
    WEBER, MA
    BYYNY, RL
    PRATT, JH
    FAISON, EP
    SNAVELY, DB
    GOLDBERG, AI
    NELSON, EB
    ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (04) : 405 - 411
  • [24] BLOOD-PRESSURE RESPONSE TO AN ANGIOTENSIN-II ANTAGONIST IN PATIENTS WITH ACROMEGALY
    OGIHARA, T
    HATA, T
    MARUYAMA, A
    MIKAMI, H
    NAKAMARU, M
    OKADA, Y
    KUMAHARA, Y
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 48 (01): : 159 - 162
  • [25] ROLE OF VASOPRESSIN IN CARDIOVASCULAR AND BLOOD-PRESSURE REGULATION
    ABBOUD, FM
    FLORAS, JS
    AYLWARD, PE
    GUO, GB
    GUPTA, BN
    SCHMID, PG
    BLOOD VESSELS, 1990, 27 (2-5): : 106 - 115
  • [26] EVIDENCE THAT UREA ENHANCES THE EFFECT OF ANGIOTENSIN-II (A-II) ON BLOOD-PRESSURE
    CHAN, JCM
    CORLEY, KC
    MAUCK, HP
    KIDNEY INTERNATIONAL, 1979, 16 (06) : 792 - 792
  • [27] EFFECTS OF ANGIOTENSIN-II ON BLOOD-PRESSURE, PRA, AND ALDOSTERONE IN THE FETAL LAMB
    SIEGEL, SR
    NATHANIELSZ, PW
    FISHER, DA
    CLINICAL RESEARCH, 1979, 27 (01): : A129 - A129
  • [28] ANGIOTENSIN-II DEGRADATION AND BLOOD-PRESSURE IN CHRONIC RENAL-FAILURE
    CARPI, A
    PALLA, R
    PUNTONI, R
    DONATO, L
    KIDNEY INTERNATIONAL, 1975, 8 (02) : 124 - 125
  • [29] ANGIOTENSIN-II ALTERS BLOOD-PRESSURE DURING VOLUME LOADING IN HUMANS
    GOLDSMITH, SR
    MILLER, EA
    CIRCULATION, 1992, 86 (04) : 484 - 484
  • [30] SYSTEMIC ANGIOTENSIN-II, BLOOD-PRESSURE AND SUPRAOPTIC NEURONAL-ACTIVITY
    MITCHELL, LD
    CALLAHAN, MF
    WILKIN, LD
    BELLIN, SI
    JOHNSON, AK
    PEPTIDES, 1985, 6 : 153 - 158